HC Wainwright initiated coverage on Milestone Pharmaceuticals with a new price target
$MIST
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright initiated coverage of Milestone Pharmaceuticals with a rating of Buy and set a new price target of $20.00